Compound details
3,4-Methylenedioxybenzaldehyde
| Compound ID | CDAMM00799 |
|---|---|
| Common name | 3,4-Methylenedioxybenzaldehyde | IUPAC name | 1,3-benzodioxole-5-carbaldehyde |
| Molecular formula | C8H6O3 |
| Retention time | 12.6 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 151.041 | Theoretical mz | 151.039 |
| Error | 12.08 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.5573 |
| Inchi key | SATCULPHIDQDRE-UHFFFAOYSA-N |
|---|---|
| Smiles | O=CC1=CC=C2OCOC2=C1 |
| Superclass | Organoheterocyclic compounds |
| Class | Benzodioxoles |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P27338 | MAOB | Monoamine oxidase B | T83011 | SEA |
| P11509 | CYP2A6 | Cytochrome P450 2A6 | T06455 | SEA |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SEA |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SEA |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | T82720 | SEA |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SEA |
| Q00535 | CDK5 | Cyclin-dependent kinase 5/CDK5 activator 1 | T20973 | SEA |
| P49761 | CLK3 | Dual specificity protein kinase CLK3 | T21585 | SEA |
| P17936 | IGFBP3 | Insulin-like growth factor binding protein 3 | T33455 | SEA |
| Q92630 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | T39486 | SEA |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| Q7RTX1 | TAS1R1 | Taste receptor | T41263 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T06455 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P11509 | CYP2A6 |
| T06455 | DI0351 | Psoriasis | [ICD-11: EA90] | P11509 | CYP2A6 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T20973 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q00535 | CDK5 |
| T33455 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P17936 | IGFBP3 |
| T41263 | DI0078 | Cholera | [ICD-11: 1A00] | Q7RTX1 | TAS1R1 |